| Name | Title | Contact Details |
|---|
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
LEARN Behavioral is a national organization that specializes in providing tailored treatment programs for children and young adults with autism spectrum disorder (ASD). We use contemporary applied behavior analysis (ABA) therapy that is based on the un...
Calhoun Vision is focused on developing vision correction technologies for post-cataract surgery patients.
MedAmerica is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Midtown Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Ogden, UT. To find more information about Midtown Community Health Center, please visit www.midtownchc.org